This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Outcomes of Warfarin Therapy for Bioprosthetic Valve Thrombosis of Surgically Implanted Valves

Sunday, February 26, 2017

Submitted by


Source Name: JACC Cardiovascular Interventions


Alexander C. Egbe, Heidi M. Connolly, Patricia A. Pellikka, Hartzell V. Schaff, Richard Hanna, Joseph J. Maleszewski, Vuyisile T. Nkomo, Sorin V. Pislaru

In this manuscript, the authors describe their findings in an observational prospective study of 52 patients who had tentative diagnoses of bioprosthetic valve thrombosis (BPVT) of surgically implanted valves over a 3-year period. All patients underwent a trial of anticoagulation therapy with warfarin, and follow-up transthoracic or transesophageal echocardiography performed at least 4 weeks after the initiation of anticoagulation therapy. The authors found that an echocardiographic diagnostic score predicted the response to warfarin anticoagulation in BPVT with excellent accuracy, that warfarin significantly reduced prosthetic gradients in 83% of the patients; and that this diagnostic and therapeutic strategy was associated with minimal side effects and no mortality.


I was surprised but heartened by the high success rate of this approach.

Add comment

Log in or register to post comments